Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. After CVS made Novo Nordisk its ...

HANGZHOU, June 1 (Reuters) - U.S. drugmaker Eli Lilly has entered into an agreement to collaborate on and possibly licence ...

Macro strategist Jordi Visser delivered a striking observation on a recent episode of The Pomp Podcast with Anthony Pompliano ...

David Ricks was addressing the pharmaceutical titan's latest hot product.

The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...

By Sriparna Roy May 26 (Reuters) - Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to $3.8 ...

Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

By Sriparna Roy May 28 (Reuters) - CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ...

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered ...

Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion, leveraging its obesity-fueled dominance to establish itself as a leader in other areas and become a major ...